Sabra Financial Statements From 2010 to 2026

SBRA Stock  USD 20.03  0.56  2.72%   
Sabra Healthcare's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Sabra Healthcare's valuation are provided below:
Gross Profit
505.7 M
Profit Margin
0.2006
Market Capitalization
5.1 B
Enterprise Value Revenue
9.7686
Revenue
775.8 M
We have found one hundred twenty available fundamental trend indicators for Sabra Healthcare REIT, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Sabra Healthcare REIT current market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 4.3 B, whereas Enterprise Value is forecasted to decline to about 3.3 B.

Sabra Healthcare Total Revenue

455.77 Million

Check Sabra Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sabra Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 139.3 M, Interest Expense of 88.4 M or Selling General Administrative of 33 M, as well as many indicators such as Price To Sales Ratio of 9.57, Dividend Yield of 0.0967 or PTB Ratio of 1.55. Sabra financial statements analysis is a perfect complement when working with Sabra Healthcare Valuation or Volatility modules.
  
Build AI portfolio with Sabra Stock
Check out the analysis of Sabra Healthcare Correlation against competitors.

Sabra Healthcare Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.4 B5.5 BB
Slightly volatile
Short and Long Term Debt Total2.2 B1.3 BB
Slightly volatile
Total Current Liabilities1.3 B1.3 B248.9 M
Slightly volatile
Total Stockholder Equity2.2 B2.8 B2.1 B
Slightly volatile
Other Liabilities47.8 M40.4 M49 M
Very volatile
Property Plant And Equipment Net3.2 B5.3 B3.2 B
Slightly volatile
Net Debt1.9 B1.2 B1.7 B
Slightly volatile
Accounts Payable74 M78 M68.3 M
Slightly volatile
Cash85.6 M71.5 M78.2 M
Very volatile
Non Current Assets Total62.1 M65.3 M3.2 B
Slightly volatile
Other Assets5.5 B5.2 B1.7 B
Slightly volatile
Long Term Debt2.4 B2.3 B1.1 B
Slightly volatile
Cash And Short Term Investments85.6 M71.5 M78.2 M
Very volatile
Common Stock Total Equity2.8 M2.7 M1.5 M
Slightly volatile
Common Stock Shares Outstanding147.7 M244.5 M135.1 M
Slightly volatile
Short Term Investments20.7 M21.8 M63 M
Slightly volatile
Liabilities And Stockholders Equity4.4 B5.5 BB
Slightly volatile
Non Current Liabilities Total1.9 B1.4 B1.8 B
Slightly volatile
Other Stockholder Equity3.1 B4.8 B2.8 B
Slightly volatile
Total Liabilities2.1 B2.7 BB
Slightly volatile
Property Plant And Equipment Gross627.4 M757.1 M652 M
Slightly volatile
Total Current Assets332.1 M182.8 M303.7 M
Pretty Stable
Common Stock1.6 M2.5 M1.4 M
Slightly volatile
Intangible Assets58.4 M65.3 M50.5 M
Slightly volatile
Net Tangible Assets2.4 B3.5 B2.1 B
Slightly volatile
Net Receivables220.1 M111.3 M179.1 M
Slightly volatile
Long Term Debt Total2.8 B2.7 B1.2 B
Slightly volatile
Capital Surpluse2.9 B5.2 B2.7 B
Slightly volatile
Short Term Debt1.3 B1.3 B546.6 M
Slightly volatile
Long Term Investments172.4 M183.5 M124.7 M
Slightly volatile
Short and Long Term Debt206.7 M217.6 M767.9 M
Slightly volatile
Capital Lease Obligations20.3 M21.4 M69.9 M
Slightly volatile
Net Invested Capital4.6 B5.4 B6.1 B
Slightly volatile
Non Current Liabilities Other49.6 M29.3 M72.4 M
Slightly volatile
Capital Stock2.4 M2.5 MM
Slightly volatile

Sabra Healthcare Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization139.3 M187 M127.4 M
Slightly volatile
Selling General Administrative33 M53.7 M30.2 M
Slightly volatile
Total Revenue455.8 M774.6 M416.8 M
Slightly volatile
Gross Profit365.2 M503.5 M333.9 M
Slightly volatile
Other Operating Expenses260.5 M510.8 M238.2 M
Slightly volatile
Operating Income211.9 M263.9 M193.7 M
Slightly volatile
EBITDA290.6 M456.8 M265.8 M
Slightly volatile
Total Operating Expenses170.1 M239.7 M155.6 M
Slightly volatile
Cost Of Revenue284.7 M271.1 M101.3 M
Slightly volatile
Net Income From Continuing Ops84 M155.5 M93.7 M
Pretty Stable
Preferred Stock And Other Adjustments10.8 M11.2 M9.6 M
Slightly volatile
Tax Provision1.8 M1.8 M1.4 M
Slightly volatile
Reconciled Depreciation192.7 M187 M150.6 M
Slightly volatile
Interest Income6.7 M7.8 M6.1 M
Slightly volatile

Sabra Healthcare Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation8.4 M11.4 M7.7 M
Slightly volatile
Depreciation126.8 M187 M116 M
Slightly volatile
Total Cash From Operating Activities234 M348.6 M214 M
Slightly volatile
End Period Cash Flow88.5 M78.1 M80.9 M
Very volatile
Begin Period Cash Flow93.7 M66.3 M85 M
Very volatile
Issuance Of Capital Stock166 M227.8 M256.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.575.90028.7549
Slightly volatile
Dividend Yield0.09670.06330.0884
Pretty Stable
PTB Ratio1.551.61971.4158
Slightly volatile
Days Sales Outstanding49.8252.4398156
Slightly volatile
Book Value Per Share12.0711.701814.9099
Very volatile
Operating Cash Flow Per Share1.271.44471.5728
Very volatile
Stock Based Compensation To Revenue0.01390.01470.0292
Slightly volatile
Capex To Depreciation0.210.222.116
Slightly volatile
PB Ratio1.551.61971.4158
Slightly volatile
EV To Sales7.067.430714.6384
Slightly volatile
Payables Turnover0.490.470.3309
Slightly volatile
Sales General And Administrative To Revenue0.110.06930.0974
Slightly volatile
Capex To Revenue0.06450.06790.6276
Slightly volatile
Cash Per Share0.280.29640.84
Slightly volatile
POCF Ratio16.713.110415.2648
Slightly volatile
Interest Coverage1.822.34572.1929
Pretty Stable
Capex To Operating Cash Flow0.10.111.5065
Slightly volatile
Days Payables Outstanding7638031.8 K
Slightly volatile
EV To Operating Cash Flow29.2916.511226.789
Slightly volatile
Intangibles To Total Assets0.01360.01190.0122
Pretty Stable
Net Debt To EBITDA2.472.595210.4855
Slightly volatile
Current Ratio0.140.14543.7686
Slightly volatile
Tangible Book Value Per Share11.8411.431114.6255
Very volatile
Receivables Turnover7.316.96044.4302
Very volatile
Graham Number12.6513.025514.2378
Pretty Stable
Shareholders Equity Per Share12.0611.693714.9049
Very volatile
Debt To Equity0.420.44551.0593
Slightly volatile
Capex Per Share0.170.182.0633
Slightly volatile
Revenue Per Share2.473.21013.054
Very volatile
Interest Debt Per Share5.395.675615.702
Slightly volatile
Debt To Assets0.220.22880.4697
Slightly volatile
Enterprise Value Over EBITDA11.9712.599925.1716
Slightly volatile
Short Term Coverage Ratios0.260.277337.8126
Slightly volatile
Operating Cycle49.8252.4398156
Slightly volatile
Price Book Value Ratio1.551.61971.4158
Slightly volatile
Days Of Payables Outstanding7638031.8 K
Slightly volatile
Price To Operating Cash Flows Ratio16.713.110415.2648
Slightly volatile
Operating Profit Margin0.530.34060.4729
Pretty Stable
Company Equity Multiplier2.411.94672.2067
Slightly volatile
Long Term Debt To Capitalization0.560.45030.5121
Slightly volatile
Total Debt To Capitalization0.550.30820.5075
Slightly volatile
Return On Capital Employed0.04180.06230.0507
Very volatile
Debt Equity Ratio0.420.44551.0593
Slightly volatile
Ebit Per Revenue0.530.34060.4729
Pretty Stable
Quick Ratio0.140.14543.7686
Slightly volatile
Dividend Paid And Capex Coverage Ratio0.751.20420.926
Slightly volatile
Net Income Per E B T0.940.9893.0973
Slightly volatile
Cash Ratio0.05410.05690.892
Slightly volatile
Operating Cash Flow Sales Ratio0.580.450.5329
Pretty Stable
Days Of Sales Outstanding49.8252.4398156
Slightly volatile
Cash Flow Coverage Ratios0.290.27730.1274
Slightly volatile
Price To Book Ratio1.551.61971.4158
Slightly volatile
Fixed Asset Turnover67.964.6633.2116
Slightly volatile
Capital Expenditure Coverage Ratio10.029.544.4338
Slightly volatile
Price Cash Flow Ratio16.713.110415.2648
Slightly volatile
Enterprise Value Multiple11.9712.599925.1716
Slightly volatile
Debt Ratio0.220.22880.4697
Slightly volatile
Cash Flow To Debt Ratio0.290.27730.1274
Slightly volatile
Price Sales Ratio9.575.90028.7549
Slightly volatile
Asset Turnover0.080.1410.0995
Slightly volatile
Gross Profit Margin0.910.650.8694
Slightly volatile
Price Fair Value1.551.61971.4158
Slightly volatile

Sabra Healthcare Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.3 B4.1 B2.4 B
Slightly volatile
Enterprise Value3.3 B5.2 B3.9 B
Slightly volatile

Sabra Fundamental Market Drivers

Forward Price Earnings8.7108
Cash And Short Term Investments71.5 M

Sabra Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Sabra Healthcare Financial Statements

Sabra Healthcare stakeholders use historical fundamental indicators, such as Sabra Healthcare's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sabra Healthcare investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sabra Healthcare's assets and liabilities are reflected in the revenues and expenses on Sabra Healthcare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sabra Healthcare REIT. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-84.9 M-89.1 M
Total Revenue774.6 M455.8 M
Cost Of Revenue271.1 M284.7 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.07  0.11 
Capex To Revenue 0.07  0.06 
Revenue Per Share 3.21  2.47 
Ebit Per Revenue 0.34  0.53 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:
Check out the analysis of Sabra Healthcare Correlation against competitors.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Sabra Healthcare assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
(0.45)
Dividend Share
1.2
Earnings Share
0.62
Revenue Per Share
3.215
Quarterly Revenue Growth
0.158
Understanding Sabra Healthcare REIT requires distinguishing between market price and book value, where the latter reflects Sabra's accounting equity. The concept of intrinsic value - what Sabra Healthcare's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Sabra Healthcare's price substantially above or below its fundamental value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Sabra Healthcare's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.